A utility patent was approved for Medicortex in China

Adrian Harel (adrian.harel a medicortex.fi), Nov 13th 2020

Utility model application No. 201890000516.8 in China (national phase of PCT/IB2018/050698) "NON-INVASIVE BRAIN INJURY DIAGNOSTIC DEVICE” was approved. The patent protects the technology related to the measurement of our proprietary biomarker we found from patients with a concussion.
This is the second patent that has been granted to Medicortex – earlier this year a patent protecting the novel biomarker for concussion diagnostics was approved in the USA as well as Europe.